• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Welcure Drugs & Pharmaceuticals Ltd — Board Meeting, 27-09-2025: Board Meeting

    27-09-2025 | 06:00 pm

    Welcure's Board confirmed Telexcell can acquire up to 25% at ₹20/share (double market price) but rejected management control. Deals must be secondary, ensuring no dilution or company liability. This strengthens Welcure's valuation and independence for shareholders.

    No comments yet. Be the first to comment!

    All announcements from Welcure Drugs & Pharmaceuticals Ltd